" class="no-js "lang="en-US"> Ori Biotech - Medtech Alert
Friday, September 12, 2025
Ori Biotech | Pharmtech Focus

Ori Biotech

About Ori Biotech

Ori Biotech

Ori Biotech is a London- and New Jersey-based innovator in CGT manufacturing that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalised, lifesaving treatments.

By fully automating and standardising CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing.

So complex manufacturing challenges can be put where they belong – in the past.

Related Story

Ori Biotech Raises Over $100 Million in Series B Funding to Launch Innovative Cell and Gene Therapy Manufacturing Platform

January 19 2022

Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces […]